An international consensus statement on the management of postoperative anaemia after major surgical procedures

Anaesthesia

Volumn 73, Issue 11, 2018, Pages 1418-1431

  Munoz M ^a   Acheson, A G ^b   Bisbe, E ^c   Butcher, A ^d   Gomez Ramirez S ^e   Khalafallah, A A ^f,g   Kehlet, H ^h   Kietaibl, S ⁱ   Liumbruno, G M ^j   Meybohm, P ^k   Rao Baikady, R ^l   Shander, A ^m,n   So Osman, C ^o,p   Spahn, D R ^q   Klein, A A ^r  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c Department of Anesthesiology   (Spain)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^f LAUNCESTON GENERAL HOSPITAL   (Australia)

^g UNIVERSITY OF TASMANIA   (Australia)

^h Rigshospitalet   (Denmark)

ⁱ Evangelical Hospital   (Austria)

^j ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^k UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^l INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^m ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

ⁿ TeamHealth Research Institute   (United States)

^o CENTRAL LABORATORY   (Netherlands)

^p GROENE HART HOSPITAL   (Netherlands)

^q UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^r PAPWORTH HOSPITAL   (United Kingdom)

more..

Author keywords

anaemia; erythropoiesis stimulating agents; iron deficiency; iron supplementation; postoperative period; transfusion

Indexed keywords

ANTIANEMIC AGENT; IRON;

ANEMIA; CONSENSUS; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; FOLLOW UP; HEALTH CARE NEED; HUMAN; IRON DEFICIENCY; IRON THERAPY; MAJOR SURGERY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT IDENTIFICATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SURGICAL PATIENT; BLOOD TRANSFUSION; CONSENSUS DEVELOPMENT; INTERNATIONAL COOPERATION; SURGERY;

ANEMIA; BLOOD TRANSFUSION; CONSENSUS; HUMANS; INTERNATIONALITY; IRON; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE;

EID: 85051147059     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.14358     Document Type: Review

References (114)

1. SABM. Anemia prevention and management program implementation guide. 2015. https://www.sabm.org/sites/default/files/anemia_prevention_management_program_implementation_guide.pdf (accessed 11/10/2017).
2. Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017; 57: 1347–58.
3. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S, et al. ‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients. British Journal of Anaesthesia 2015; 115: 15–24.
4. Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233–47.
5. Meybohm P, Richards T, Isbister J, et al. Patient blood management bundles to facilitate implementation. Transfusion Medicine Reviews 2017; 31: 62–71.
6. Spahn DR. Patient blood management: the new standard. Transfusion 2017; 57: 1325–7.
7. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. First update 2016. European Journal of Anaesthesiology 2017; 43: 332–95.
8. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. British Journal of Anaesthesia 2008; 100: 599–604.
9. National Blood Authority. Patient blood management guidelines: Module 2 - Perioperative. https://www.blood.gov.au/pbm-module-2 (accessed 11/10/2017).
10. Leal-Noval SR, Muñoz M, Asuero M, et al. Spanish expert panel on alternatives to allogeneic blood transfusion. Spanish consensus statement on alternatives to allogeneic blood transfusion: the 2013 update of the ‘Seville Document’. Blood Transfusion 2013; 11: 585–610.
11. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015; 122: 241–75.
12. NICE guideline [NG24]. Blood transfusion. https://www.nice.org.uk/guidance/ng24/chapter/Recommendations#alternatives-to-blood-transfusion-for-patients-having-surgery-2 (accessed 27/06/2017).
13. Vaglio S, Prisco D, Biancofiore G, et al. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. Blood Transfusion 2016; 14: 23–65.
14. Kotzé A, Harris A, Baker C, et al. British committee for standards in haematology guidelines on the identification and management of pre-operative anaemia. British Journal of Haematology 2015; 171: 322–31.
15. Muñoz M, Peña-Rosas JP, Robinson S, et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfusion Medicine 2017; 28: 22–39.
16. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. American Journal of Medicine 2004; 116: 58S–69S.
17. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113: 482–95.
18. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. WHO/NMH/NHD/MNM/11.1. http://www.who.int/vmnis/indicators/haemoglobin.pdf (accessed 28/04/2017).
19. Butcher A, Richards T, Stanworth SJ, Klein AA. Diagnostic criteria for pre-operative anaemia–time to end sex discrimination. Anaesthesia 2017; 72: 811–814.
20. Muñoz M, Shander A, Rijhwani T, Dyga R, Waters JH. Postoperative blood management strategies. In: Frank SM, Waters JH, eds. Patient blood management: multidisciplinary approaches to optimizing care. Bethesda, MD: AABB Press, 2016: 233–58.
21. Hayn D, Kreiner K, Kastner P, et al. Data driven methods for predicting blood transfusion needs in elective surgery. Studies in Health Technology and Informatics 2016; 223: 9–16.
22. Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Current Opinion in Hematology 2005; 12: 123–8.
23. Gómez-Ramírez S, Remacha-Sevilla ÁF, Muñoz-Gómez M. Anaemia in the elderly. Medicina Clinica (Barcelona) 2017; 149: 496–503.
24. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Critical Care Medicine 2000; 28: 2773–8.
25. van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel A. Iron metabolism and erythropoiesis after surgery. British Journal of Surgery 1998; 85: 41–5.
26. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: Iron deficiency and iron overload. Journal of Clinical Pathology 2011; 64: 287–296.
27. Goodnough LT, Maggio P, Hadhazy E, et al. Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion 2014; 54: 2753–9.
28. So-Osman C1, Nelissen R, Brand R, Brand A, Stiggelbout AM. Postoperative anemia after joint replacement surgery is not related to quality of life during the first two weeks postoperatively. Transfusion 2011; 51: 71–81.
29. Vuille-Lessard E, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF. Postoperative anemia does not impede functional outcome and quality of life early after hip and knee arthroplasties. Transfusion 2012; 52: 261–70.
30. Jans O, Bandholm T, Kurbegovic S, et al. Postoperative anemia and early functional outcomes after fast-track hip arthroplasty: a prospective cohort study. Transfusion 2016; 56: 917–25.
31. Koch CG, Li L, Sun Z, et al. Magnitude of anemia at discharge increases 30-day hospital readmissions. Journal of Patient Safety 2017; 13: 202–6.
32. Choi YJ, Kim SO, Sim JH, Hahm KD. Postoperative anemia is associated with acute kidney injury in patients undergoing total hip replacement arthroplasty: a retrospective study. Anesthesia and Analgesia 2016; 122: 1923–8.
33. Pitter FT, Jorgensen CC, Lindberg-Larsen M, Kehlet H. Postoperative morbidity and discharge destinations after fast-track hip and knee arthroplasty in patients older than 85 years. Anesthesia and Analgesia 2016; 122: 1807–15.
34. Jorgensen CC, Kehlet H. Early thromboembolic events
35. Gayat E, Aulagnier J, Matthieu E, Boisson M, Fischler M. Non-invasive measurement of hemoglobin: assessment of two different point-of-care technologies. PLoS ONE 2012; 7: e30065.
36. Barker SJ, Shander A, Ramsay MA. Continuous noninvasive hemoglobin monitoring: a measured response to a critical review. Anesthesia and Analgesia 2016; 122: 565–72.
37. Noumi BL, Teruya S, Salomon S, Helmke S, Maurer MS. Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia. Congestive Heart Failure 2011; 17: 14–8.
38. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. Journal of Clinical Pathology 2011; 64: 281–6.
39. Khalafallah AA, Yan C, Al-Badri R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematology 2016; 3: e415–25.
40. Cappellini MD, Comin-Colet J, de Francisco A, et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis and management. American Journal of Hematology 2017; 92: 1068–78.
41. Thomas L, Thomas C. Detection of iron restriction in anaemic and non-anaemic patients: new diagnostic approaches. European Journal of Haematology 2017; 99: 262–8.
42. Bisbe E, Moltó L, Arroyo R, Muniesa JM, Tejero M. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. British Journal of Anaesthesia 2014; 113: 402–9.
43. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J. Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. Blood Transfusion 2014; 12: 40–9.
44. ® ) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sanguinis 2015; 109: 257–66.
45. Kim YW, Bae JM, Park YK, et al. and study group. Effect of intravenous ferric carboxymaltose on hemoglobin response among patients with acute isovolemic anemiafollowing gastrectomy: the FAIRY randomized clinical trial. Journal of the American Medical Association 2017; 317: 2097–104.
46. Holm C, Thomsen LL, Norgaard A, Langhoff-Roos J. Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial. Vox Sanguinis 2017; 112: 219–28.
47. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P. Rossetti G; Italian Society of Transfusion Medicine and Immunohaematology Working Party. Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period. Blood Transfusion 2011; 9: 320–35.
48. Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia 2016; 71: 829–42.
49. Carson JL, Guyatt G, Heddle NM, et al. Red blood cell transfusion: 2016 clinical practice guideline from the AABB. Annals of Internal Medicine 2016; 316: 2025–35.
50. Vaglio S, Gentili S, Marano G, et al. The Italian regulatory guidelines for the implementation of patient blood management. Blood Transfusion 2017; 15: 325–8.
51. Crosby L, Palarski VA, Cottington E, Cmolik B. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart and Lung 1994; 23: 493–9.
52. Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T. Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo. Journal of Bone and Joint Surgery Britain 2004; 86: 31–3.
53. Weatherall M, Maling TJ. Oral iron therapy for anaemia after orthopaedic surgery: randomized clinical trial. ANZ Journal of Surgery 2004; 74: 1049–51.
54. Mundy GM, Birtwistle SJ, Power RA. The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty. Journal of Bone and Joint Surgery Britain 2005; 87: 213–7.
55. Zauber NP, Zauber AG, Gordon FJ, et al. Iron supplementation after femoral head replacement for patients with normal iron stores. Journal of the American Medical Association 1992; 267: 525–7.
56. Prasad N, Rajamani V, Hullin D, Murray JM. Post-operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury 2009; 40: 1073–6.
57. Parker MJ. Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. Journal of Bone and Joint Surgery America 2010; 92: 265–9.
58. Madi-Jebara SN, Sleilaty GS, Achouh PE, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 2004; 18: 59–63.
59. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Canadian Journal of Anesthesia 2006; 53: 11–9.
60. Mudge DW, Tan KS, Miles R, et al. A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation. Transplantation 2012; 93: 822–6.
61. Titos-Arcos JC, Soria-Aledo V, Carrillo-Alcaraz A, Ventura-López M, Palacios-Muñoz S, Pellicer-Franco E. Is intravenous iron useful for reducing transfusions in surgically treated colorectal cancer patients? World Journal of Surgery 2012; 36: 1893–7.
62. Garrido-Martín P, Nassar-Mansur MI, de la Llana-Ducrós R, et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interactive Cardiovascular Thoracic Surgery 2012; 15: 1013–8.
63. Jeong O, Park YK. Effect of intravenous iron supplementation for acute postoperative anemia in patients undergoing gastrectomy for gastric carcinoma: a pilot study. Annals of Surgical Oncology 2014; 21: 547–52.
64. Muñoz M, Gómez-Ramírez S, Besser M, et al. Current misconceptions in diagnosis and management of iron deficiency. Blood Transfusion 2017; 15: 422–37.
65. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet 2007; 369: 1502–4.
66. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clinic Proceedings 2015; 90: 12–23.
67. European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron containing medicines. EMA/579491/2013. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/IV_iron_31/WC500151308.pdf (accessed: 18/06/2017).
68. Auerbach M, Adamson J, Bircher A, et al. On the safety of intravenous iron, evidence trumps conjecture. Haematologica 2015; 100: e214–5.
69. Szebeni J, Fishbane S, Hedenus M, et al. Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. British Journal of Pharmacology 2015; 172: 5025–36.
70. Macdougall IC, Bircher AJ, Eckardt KU, et al. Conference Participants. Iron management in chronic kidney disease: conclusions from a ‘Kidney Disease: Improving Global Outcomes’ (KDIGO) Controversies Conference. Kidney International 2016; 89: 28–39.
71. Rampton D, Folkersen J, Fishbane S, et al. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 2014; 99: 1671–6.
72. Ganz T. Iron in innate immunity: starve the invaders. Current Opinion in Immunology 2009; 21: 63–7.
73. Andrews SC, Robinson AK, Rodríguez-Quiñones F. Bacterial iron homeostasis. FEMS Microbiology Reviews 2003; 27: 215–37.
74. Pratt JJ, Khan KS. Non-anaemic iron deficiency – a disease looking for recognition of diagnosis: a systematic review. European Journal of Haematology 2016; 96: 618–28.
75. Sharma R, Stanek JR, Koch TL, et al. Intravenous iron therapy in non-anemic iron-deficient menstruating adolescent females with fatigue. American Journal of Hematology 2016; 91: 973–7.
76. Burden RJ, Morton K, Richards T, et al. Is iron treatment beneficial in, iron-deficient but non-anaemic (IDNA) endurance athletes? A systematic review and meta-analysis. British Journal of Sports Medicine 2015; 49: 1389.
77. Pittori C, Buser A, Gasser UE, et al. A pilot iron substitution programme in female blood donors with iron deficiency without anaemia. Vox Sanguinis 2011; 100: 303–11.
78. Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011; 118: 3222–7.
79. Anker SD, Comin Colet J, Filippatos G, et al. FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. New England Journal of Medicine 2009; 361: 2436–48.
80. Jankowska EA, Tkaczyszyn M, Suchocki T, et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. European Journal of Heart Failure 2016; 18: 786–95.
81. Goodnough LT, Comin-Colet J, Leal-Noval S, et al. Management of anemia in patients with congestive heart failure. American Journal of Hematology 2017; 92: 88–93.
82. Harju E. Empty iron stores as a significant risk factor in abdominal surgery. Journal of Parenteral and Enteral Nutrition 1988; 12: 282–5.
83. Piednoir P, Allou N, Driss F, et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. European Journal of Anaesthesiology 2011; 28: 796–801.
84. Miles LF, Kunz SA, Na LH, Braat S, Burbury K, Story DA. Postoperative outcomes following cardiac surgery in non-anaemic iron-replete and iron-deficient patients - an exploratory study. Anaesthesia 2017; 73: 450–458.
85. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. British Journal of Anaesthesia 2011; 106: 13–22.
86. Kulnigg-Dabsch S, Schmid W, Howaldt S, et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflammatory Bowel Diseases 2013; 19: 1609–16.
87. Henry DH, Dahl NV, Auerbach MA. Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron. American Journal of Hematology 2012; 87: 308–10.
88. Hazara AM, Bhandari S. Intravenous iron infusion reduces platelet counts in patients with chronic kidney disease. Journal of Clinical Pharmacology Therapeutic 2015; 40: 20–23.
89. Kaiafa G, Savopoulos C, Kanellos I, et al. Anemia and stroke: where do we stand? Acta Neurologica Scandinavica 2017; 135: 596–602.
90. French CJ, Glassford NJ, Gantner D, et al. Erythropoiesis-stimulating Agents in Critically Ill Trauma Patients: a Systematic Review and Meta-analysis. Annals of Surgery 2017; 265: 54–62.
91. Penny-Dimri JC, Cochrane AD, Perry LA, Smith JA. Characterising the role of perioperative erythropoietin for preventing acute kidney injury after cardiac surgery: systematic review and meta-analysis. Heart Lung Circulation 2016; 25: 1067–76.
92. Lakič N, Mrak M, Šušteršič M, Rakovec P, Bunc M. Perioperative erythropoietin protects the CNS against ischemic lesions in patients after open heart surgery. Wiener Klinische Wochenschrift 2016; 128: 875–81.
93. Weltert L, Rondinelli B, Bello R, et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion 2015; 55: 1644–54.
94. Cuenca J, García-Erce JA, Martínez F, Pérez-Serrano L, Herrera A, Muñoz M. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006; 46: 1112–9.
95. Bernabeu-Wittel M, Romero M, Ollero-Baturone M, et al. PAHFRAC-01 Investigators. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion 2016; 56: 2199–211.
96. García-Erce JA, Cuenca J, Haman-Alcober S, Martínez AA, Herrera A, Muñoz M. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sanguinis 2009; 97: 260–7.
97. Muñoz M, Gómez-Ramírez S, Auerbach M. Stimulating erythropoiesis before hip fracture repair for reducing blood transfusion: should we change the hemoglobin cutoff level for defining anemia in females? Transfusion 2016; 56: 2160–3.
98. Meybohm P, Herrmann E. Steinbicker AU; PBM-study Collaborators. Patient Blood Management is associated with a substantial reduction of red blood cell utilization and safe for patient's outcome: a prospective, multicenter cohort study with a non-inferiority design. Annals of Surgery 2016; 264: 203–11.
99. Goodnough LT, Shieh L, Hadhazy E, et al. Improved blood utilization using real-time clinical decision support. Transfusion 2014; 54: 1358–65.
100. Gross I, Seifert B, Hofmann A, et al. Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion 2015; 55: 1075–81.
101. Franchini M, Marano G, Mengoli C, et al. Red blood cell transfusion policy: a critical literature review. Blood Transfusion 2017; 15: 307–17.
102. Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A. Adverse blood transfusion outcomes: establishing causation. Transfusion Medicine Reviews 2011; 25: 89–101.
103. Curley GF, Shehata N, Mazer CD, Hare GM, Friedrich JO. Transfusion thresholds for guiding RBC transfusion for cardiovascular surgery: a systematic review and meta-analysis. Critical Care Medicine 2014; 42: 2611–24.
104. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a metaanalysis and systematic review. American Journal of Medicine 2014; 127: 124–31.
105. Brunskill SJ, Millette SL, Shokoohi A, et al. Red blood cell transfusion for people undergoing hip fracture surgery. Cochrane Database of Systematic Reviews 2015; 4: CD009699.
106. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. British Medical Journal 2015; 350: h1354.
107. Ripollés Melchor J, Casans Francés R, Espinosa A, et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion in critically ill patients and in patients with acute coronary syndrome: s systematic review, meta-analysis and trial sequential analysis. Minerva Anestesiologica 2016; 82: 582–98.
108. Carson JL, Stanworth SJ, Roubinian NR, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2016; 10: CD002042.
109. Liumbruno GM, Vaglio S, Biancofiore G, et al. Transfusion thresholds and beyond. Blood Transfusion 2016; 14: 123–5.
110. de Almeida JP, Vincent JL, Galas FR, et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology 2015; 122: 29–38.
111. Bergamin FS, Almeida JP, Landoni G, et al. Liberal Versus restrictive transfusion strategy in critically Ill oncologic patients: the transfusion requirements in critically Ill oncologic patients randomized controlled trial. Critical Care Medicine 2017; 45: 766–73.
112. Shander A, Gross I, Hill S, Javidroozi M, Sledge S. A new perspective on best transfusion practices. Blood Transfusion 2013; 11: 193–202.
113. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S. Pre-operative haematological assessment in patients scheduled for major surgery. Anaesthesia 2016; 71(Suppl 1): 19–28.
114. Kleinerüschkamp AG, Zacharowski K, Ettwein C, et al. Cost analysis of patient blood management. Anaesthesist 2016; 65: 438–48.